News und Analysen
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Orange Africa and Middle East and Eutelsat Announce a Strategic Partnership to Accelerate the Deployment of Satellite Internet in Africa and the Middle East
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250304140609/en/
Orange Africa and Middle East (OMEA) and Eutelsat
Offshore Wind: TotalEnergies and Partners Inaugurate 640 MW Yunlin Wind Farm in Taiwan
During a ceremony held in Taipei, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and its partners announced the successful inauguration of the Yunlin offshore wind farm in Taiwan, which is now
World Rare Disease Day: ABIONYX renews its commitment to treat LCAT Deficiency (Norum's disease) and provides an update on its advances
ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated to the development of innovative biomedicines based on a recombinant apolipoprotein
Teleperformance: 2024 Annual Results
Regulatory News:
The Board of Directors of Teleperformance (TP) (Paris:TEP), a global leader in digital business services, met today and reviewed the consolidated and statutory financial
GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Dassault Systèmes Enters the Next Phase of Its Living Heart Project with AI-Powered Virtual Twins
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that a beta test is underway to evaluate a new generation of the Living Heart model that can be highly customized for
Median Technologies to Present at TD Cowen’s 45th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
BILENDI: Bilendi in 2024: a year of transformation and major strategic breakthroughs
Jeunes Agriculteurs and TotalEnergies Strengthen Their Partnership for the Energy Transition of the Agricultural World
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and Jeunes Agriculteurs (JA) announce the signing of a cooperation protocol aimed at supporting young farmers in the energy transition, thus
Biogas in France: TotalEnergies Starts Its 2nd Largest Unit in Normandy
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces the commissioning of BioNorrois, its 8th biomethane production unit1 in France, located in Fontaine-le-Dun (Normandy). It will inject 153
Dassault Systèmes Launches SOLIDWORKS SkillForce, Its Global Initiative to Empower Students in Work-Based Learning
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the launch of SOLIDWORKS SkillForce, its new global initiative to provide licenses of its SOLIDWORKS applications to
Dassault Systèmes Reveals the Next Dimension of Product Design and Manufacturing with Apple Vision Pro
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), the world leader in Virtual Twin Experience, today announced that 3D UNIV+RSES powered by the 3DEXPERIENCE platform will leverage the power
Dassault Systèmes Introduces SOLIDWORKS CPQ, Its AI-Powered Business Solution for Fast and Accurate Configure, Price and Quote Capabilities
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the launch of SOLIDWORKS CPQ, its new configure, price and quote solution on the 3DEXPERIENCE platform. SOLIDWORKS CPQ
Dassault Systèmes Announces Centric Software’s Acquisition of AI-Powered PXM Solution, Contentserv
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that its subsidiary Centric Software, the Product Lifecycle Management (PLM) market leader, has signed an agreement to
Compose MFG and Roctool Forge Strategic Agreement to Advance Composite Molding Technologies
Dassault Systèmes and KUKA Partner to Boost Robotics and Automation Efficiency for Manufacturers
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its partnership with the global industrial automation and robotics company KUKA to provide manufacturing industries with
Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
Roctool Celebrates 25 Years of Expertise with Induction Heating Solutions at JEC World 2025
Dassault Systèmes’ 3DEXPERIENCE World 2025 to Explore the AI-Powered Generative Economy
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced 3DEXPERIENCE World 2025, its annual event dedicated to the SOLIDWORKS and 3DEXPERIENCE platform user community, is taking
ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide
ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural
Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing